IFNG and neoplasm: Artemether can enhance delayed-type hypersensitivity and antibody of coagulation in normal mice, reduce the CD4+CD25+ Foxp3+ Treg cells in tumor-burdened mice spleen, increase the produce of IL-4 and IFN-γ [132].